Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus Forster

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|March 31, 2022
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspectiveAngus Forster, Michael Junger
Medical Device Technology|January 13, 2009
Approaches to the physico-chemical and mechanical characterisation of functional coatings, Part IIAngus Forster, Thomas Neudeck, Stephen Blatcher
Vaccine|October 28, 2017
Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjectsPaul Griffin, Suzanne Elliott, Kenia Krauer, et al.
Human Vaccines & Immunotherapeutics|May 7, 2021
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch<sup>TM</sup> Microneedle Delivery SystemYing Wan, Vineet Gupta, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection ArrayYing Wan, John M Hickey, Christopher Bird, et al.
Human Vaccines & Immunotherapeutics|January 31, 2022
Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settingsCristyn Davies, Melody Taba, Lucy Deng, et al.
Scientific Reports|October 29, 2020
Innate local response and tissue recovery following application of high density microarray patches to human skinDavid A Muller, Joakim Henricson, S Ben Baker, et al.
Vaccine: X|August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessmentBrian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Scientific Reports|October 5, 2017
High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responsesDavid A Muller, Germain J P Fernando, Nick S Owens, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|March 31, 2022
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspectiveAngus Forster, Michael Junger
Medical Device Technology|January 13, 2009
Approaches to the physico-chemical and mechanical characterisation of functional coatings, Part IIAngus Forster, Thomas Neudeck, Stephen Blatcher
Vaccine|October 28, 2017
Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjectsPaul Griffin, Suzanne Elliott, Kenia Krauer, et al.
Human Vaccines & Immunotherapeutics|May 7, 2021
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch<sup>TM</sup> Microneedle Delivery SystemYing Wan, Vineet Gupta, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection ArrayYing Wan, John M Hickey, Christopher Bird, et al.
Human Vaccines & Immunotherapeutics|January 31, 2022
Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settingsCristyn Davies, Melody Taba, Lucy Deng, et al.
Scientific Reports|October 29, 2020
Innate local response and tissue recovery following application of high density microarray patches to human skinDavid A Muller, Joakim Henricson, S Ben Baker, et al.
Vaccine: X|August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessmentBrian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Scientific Reports|October 5, 2017
High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responsesDavid A Muller, Germain J P Fernando, Nick S Owens, et al.
Pageof 1